Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02566824Phase 4Unknown
Phase 4, randomised, single-blind trial (3 arms), sponsored by McGill University Health Centre. Primary endpoint: Attention Deficit/Hyperactivity Disorder (ADHD) Symptomatology. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02566824.